First half of the year with 1% growth at constant exchange rates, significant impact of COVID-19 pandemic

Group sales increase 1% at constant exchange rates and decline 4% in Swiss francs as a result of continued appreciation of the Swiss franc against most currencies
Source: Roche Media News - Category: Pharmaceuticals Source Type: news